Respir Med Case Rep . Dexamethasone in severe COVID-19 infection: A case series

[tetano]

Respir Med Case Rep


. 2020 Aug 28;101205.
doi: 10.1016/j.rmcr.2020.101205. Online ahead of print.
Dexamethasone in severe COVID-19 infection: A case series


Mohamed Eliwa Hassan[SUP] 1 [/SUP], Hasan Msn Hasan[SUP] 1 [/SUP], Kannan Sridharan[SUP] 2 [/SUP], Adel Elkday[SUP] 1 [/SUP], Mohamed Ma ElSeirafi[SUP] 1 [/SUP]



Affiliations

• PMID: 32874905
• PMCID: PMC7452843
• DOI: 10.1016/j.rmcr.2020.101205

Abstract

Evidence supporting the use of dexamethasone in severe COVID-19 patients is emerging. In this case series, we share our experience in using dexamethasone in five COVID-19 infected patients with acute respiratory distress syndrome.

Keywords: COVID-19; Coronavirus; Dexamethasone; corticosteroids.